PROVIDER PROFILE · NPI 1801366984
Michelle Pozsonyi
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
526
Beneficiaries
—
Total drug cost
$765K
Distinct drugs
5
Brand share
88.8%
Top prescribed drugs
Emtricitabine/Tenofov Alafenam357 claims
Emtricitabine/Tenofovir (Tdf)85 claims
Doxycycline Hyclate43 claims
Amoxicillin/Potassium Clav25 claims
Methylprednisolone16 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE